You are here

  • Home
  • Archive
  • Volume 75, Issue Suppl 2
  • SAT0403 Treatment with Golimumab or Infliximab Reduces Health Resource Utilization and Increases Work Productivity in Patients with Ankylosing Spondylitis in The QUO-VADIS Study, A Large, Prospective Real-Life Cohort

Article info

Article menu
Download PDFPDF
Poster Presentations
Spondyloarthritis - treatment
SAT0403 Treatment with Golimumab or Infliximab Reduces Health Resource Utilization and Increases Work Productivity in Patients with Ankylosing Spondylitis in The QUO-VADIS Study, A Large, Prospective Real-Life Cohort

Authors

Citation

Sarzi-Puttini P, Van Den Bosch F, Claudepierre P, et al
SAT0403 Treatment with Golimumab or Infliximab Reduces Health Resource Utilization and Increases Work Productivity in Patients with Ankylosing Spondylitis in The QUO-VADIS Study, A Large, Prospective Real-Life Cohort
Annals of the Rheumatic Diseases 2016;75:815-816.

Publication history

  • First published July 15, 2016.
Online issue publication 
February 06, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2016, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions